By

Hudaa Croeser
ART in the time of COVID – Médecins Sans Frontières, Khayelitsha
Adaptations to facility-based DSD models presentation by Médecins Sans Frontières(MSF) for the Khayelitsha area in Cape Town. Read more here.
Read More
PEPFAR Technical Guidance in Context of COVID-19 Pandemic
PEPFAR has released updated Technical guidance for a variety of PEPFAR issues and will be updated routinely as the situation evolves. Read more here  
Read More
The World Health Organization (WHO) is advising Member States that are leading the response to the unfolding COVID-19 pandemic. The WHO Global TB Programme, along with WHO regional and country offices, has developed an information note, in collaboration with stakeholders. This note is intended to assist national TB programmes and health personnel to urgently maintain...
Read More
Dear friends, colleagues and partners, As COVID-19 spreads across the globe, we hope that each and everyone one of you is keeping safe and taking all the measures you can to flatten the curve, including social distancing, washing hands, and other hygiene measures. This year for World TB Day, the IMPAACT4TB partners had planned a...
Read More
WHO operational handbook on Tuberculosis Module 1: Prevention Tuberculosis Preventive Treatment The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Read More
Publication: WHO consolidated guidelines on Tuberculosis Module 1: Prevention Tuberculosis preventive treatment The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be...
Read More
New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five 24 March 2020 (Johannesburg, South Africa) – Today, the Aurum Institute and its...
Read More
Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Sanofi SA, and the Stop TB Partnership is pleased to announce a significant reduction in the price of rifapentine (Priftin®) manufactured by Sanofi SA. Read more here
Read More
Press Release Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low-, Lower-Middle and Upper-Middle Income Countries Aurum Institute on behalf of the IMPAACT4TB project congratulates Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Sanofi for having reached a volume-based agreement, securing a significant price discount for rifapentine (Priftin®) Hyderabad (31 October 2019)—A...
Read More
1 5 6 7 8 9